Evidence map›Paper›PMID 40703696›Full record

ArticleEwha medical journal2024

Using an influenza epidemic threshold different from those in the United States and Europe caused longer epidemic periods in Korea during the 2018-2019, 2019-2020, and 2022-2023 seasons: a comparative study.

Joowon Lee, Sooyoung Huh, Haesook Seo

Abstract read
In one paragraph

Article in Ewha medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joowon LeeInfectious Disease Research Center, Citizen's Health Bureau, Seoul Metropolitan Government, Seoul, Korea.ORCID https://orcid.org/0009-0005-7015-8238
Sooyoung HuhInfectious Disease Research Center, Citizen's Health Bureau, Seoul Metropolitan Government, Seoul, Korea.ORCID https://orcid.org/0009-0009-1113-1659
Haesook SeoInfectious Disease Research Center, Citizen's Health Bureau, Seoul Metropolitan Government, Seoul, Korea.ORCID https://orcid.org/0000-0002-3554-6172

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: During the COVID-19 pandemic, the first seasonal influenza epidemic was declared in the 37th week of 2022 in Korea and has continued through the winter of 2023-2024. However, this finding has not been observed in the United States and Europe. The present study aimed to determine whether the prolonged influenza epidemic in Korea from 2022 to 2023 was caused by using a different influenza epidemic threshold compared to the thresholds used in the United States and Europe. Methods: Korea, the United States, and Europe use different methods to set seasonal influenza epidemic thresholds. First, we calculated the influenza epidemic thresholds for influenza seasons using the different methods of those three regions. Using these epidemic thresholds, we then compared the duration of influenza epidemics for the most recent three influenza seasons. Results: The epidemic thresholds estimated by the Korean method were lower than those by the other methods, and the epidemic periods defined using the Korean threshold were estimated to be longer than those defined by the other regions' thresholds. Conclusion: A low influenza epidemic threshold may have contributed to the prolonged influenza epidemic in Korea, which was declared in 2022 and has continued until late 2023. A more reliable epidemic threshold for seasonal influenza surveillance needs to be established in Korea.

Indexed as

EpidemicshumanInfluenzaSeasonsSentinel surveillance

Identifiers

PMID40703696
PMCPMC12093619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.